ImmuPharma PLC (LON:IMM) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as low as $9.59. ImmuPharma shares last traded at $9.75, with a volume of 275,234 shares changing hands.
The company has a debt-to-equity ratio of 1.59, a quick ratio of 5.78 and a current ratio of 5.94. The company has a market capitalization of $16.08 million and a PE ratio of -1.85. The company’s fifty day moving average is GBX 10.63.
ImmuPharma Company Profile (LON:IMM)
ImmuPharma plc, a pharmaceutical company, develops drug candidates based on peptide therapeutics to treat serious medical conditions. The company's lead product candidate is the Lupuzor, which has completed Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Featured Article: What moving averages are used to define a golden cross?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.